SEC Filing Document

Company: DUKE Robotics Corp.
Ticker: DUKR
CIK: 1638911
Filing Type: DRS
Document Type: DRS
Date Filed: 2025-12-22
Accession Number: 0001213900-25-124553
Exchange: OTC
SIC Code: 3721
SIC Description: Aircraft
URL: https://www.sec.gov/Archives/edgar/data/1638911/000121390025124553/filename1.htm

Chunk 28 of 51
Word Count: 1451
Character Count: 8943

Document Content:

practicable and we are not responsible to provide indemnification if we were not given a reasonable and timely opportunity to participate in the defense of the claim at our own expense. Information related to the independence of our directors is provided under the section titled “Directors, Executive Officers and Corporate Governance.” DESCRIPTION OF OUR SECURITIES THAT WE ARE OFFERING Our authorized capital stock consists of 350,000,000 shares of common stock, $0.0001 par value per share, and 10,000,000 shares of “blank check” preferred stock, par value $0.0001 per share. As of [_], 2025, there are 54,218,813 shares of common stock outstanding. This description is intended as a summary, and is qualified in its entirety by reference to applicable Nevada law, and our Articles of Incorporation, as amended, and amended by-laws, which are filed, or incorporated by reference, as exhibits to the registration statement of which this prospectus forms a part. Units

We are offering [___] Units in this offering at a public offering price
of $[ ] per unit, and up to an additional [___] Units upon full exercise of the over-allotment option by the underwriters. Each Unit consists
of one share of our common stock and a warrant to purchase one share of our common stock at an exercise price equal to $[ ], which is
[_]% of the public offering price of the Units. Our Units will not be certificated and the shares of our common stock and the warrants
that are part of such Units must be purchased together in this offering as Units and are immediately separable and will be issued separately
in this offering. We are also registering the shares of common stock issuable upon exercise of the warrants. These securities are being
issued pursuant to an underwriting agreement between us and the underwriters. You should review the underwriting agreement and the form
of warrant, each filed as exhibits to the registration statement of which this prospectus is a part, for a complete description of the
terms and conditions applicable to the warrants.

Common Stock

Holders of our common stock
are entitled to one vote for each share held of record on all matters submitted to a vote of the stockholders, and do not have cumulative
voting rights. Subject to preferences that may be applicable to any outstanding shares of preferred stock, holders of common stock are
entitled to receive ratably such dividends, if any, as may be declared from time to time by our board of directors out of funds legally
available for dividend payments. All outstanding shares of common stock are fully paid and nonassessable, and the shares of common stock
to be issued upon completion of this offering will be fully paid and nonassessable. The holders of common stock have no preferences or
rights of cumulative voting, conversion, or pre-emptive or other subscription rights. There are no redemption or sinking fund provisions
applicable to the common stock. In the event of any liquidation, dissolution or winding-up of our affairs, holders of common stock will
be entitled to share ratably in any of our assets remaining after payment or provision for payment of all of our debts and obligations
and after liquidation payments to holders of outstanding shares of preferred stock, if any.

Warrants

As of [_], 2025, there are 15,500,000 shares of our common stock issuable
upon exercise of outstanding warrants at a weighted average exercise price of $0.65 per share.

Overview. The following
summary of certain terms and provisions of the warrants offered hereby is not complete and is subject to, and qualified in its entirety
by, the provisions of the warrant agent agreement between us, the Warrant Agent, and the form of warrant, both of which are filed as exhibits
to the registration statement of which this prospectus is a part. Prospective investors should carefully review the terms and provisions
set forth in the warrant agent agreement, including the annexes thereto, and form of warrant.

The warrants issued in this
offering entitle the registered holder to purchase one share of our common stock at a price equal to $[____] per share (based on a public
offering price of $[____] per Unit), subject to adjustment as discussed below, immediately following the issuance of such warrant and
terminating at 5:00 p.m., New York City time, five years after the closing of this offering.

The exercise price and number
of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances, including in the event of a
stock dividend or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuances
of common stock at prices below its exercise price.

Exercisability. The
warrants are exercisable at any time after their original issuance and at any time up to the date that is five (5) years after their original
issuance. The warrants may be exercised upon surrender of the warrant certificate on or prior to the expiration date at the offices of
the Warrant Agent, with the exercise form on the reverse side of the warrant certificate completed and executed as indicated, accompanied
by full payment of the exercise price, by certified or official bank check payable to us, for the number of warrants being exercised.
Under the terms of the Warrant Agreement, we must use our best efforts to maintain the effectiveness of the registration statement and
current prospectus relating to common stock issuable upon exercise of the warrants until the expiration of the warrants. If we fail to
maintain the effectiveness of the registration statement and current prospectus relating to the common stock issuable upon exercise of
the warrants, the holders of the warrants shall have the right to exercise the warrants solely via a cashless exercise feature provided
for in the warrants, until such time as there is an effective registration statement and current prospectus. Notwithstanding the foregoing,
on the expiration date of the warrants, they shall be automatically exercised via cashless exercise pursuant to the terms of the warrants.

Exercise Limitation.
A holder may not exercise any portion of a warrant to the extent that the holder, together with its affiliates and any other person or
entity acting as a group, would own more than 4.99% (or, upon election by a warrant holder prior to the issuance of such warrants, 9.99%)
of the outstanding common stock after exercise, as such percentage ownership is determined in accordance with the terms of the warrant,
except that upon at least 61 days’ prior notice from the holder to us, the holder may waive such limitation up to a percentage not
in excess of 9.99%.

Exercise Price. The exercise price per whole share of common stock purchasable upon
exercise of the warrants is $[____] per share (based on an public offering price of $[____] per Unit) or [_]% of public offering price
of the common stock. The exercise price is subject to appropriate adjustment in the event of certain stock dividends and distributions,
stock splits, stock combinations, reclassifications or similar events affecting our common stock and also upon any distributions of assets,
including cash, stock or other property to our stockholders.

Fractional Shares.
No fractional shares of common stock will be issued upon exercise of the warrants. If, upon exercise of the warrant, a holder would be
entitled to receive a fractional interest in a share, we will, upon exercise, pay a cash adjustment in respect of such fraction in an
amount equal to such fraction multiplied by the exercise price. If multiple warrants are exercised by the holder at the same time, we
shall pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the exercise price.

Transferability. Subject
to applicable laws, the warrants may be offered for sale, sold, transferred or assigned without our consent.

Amendment and Waiver.
Subject to any non-conflicting terms of the warrant agency agreement and the exercise adjustment provisions of the warrants, the warrants
may be modified or amended or the provisions thereof waived (i) with respect to an amendment or modification, upon obtaining the written
consent of the Company and the holders of at least 50.1% of the shares common stock issuable upon the exercise of the then-outstanding
warrants issued pursuant to the warrant agency agreement and (ii) in the case of a waiver, by the party against whom enforcement of any
such waived provision is sought; provided, that, in each case, if any amendment, modification or waiver disproportionately, materially
and adversely impacts a warrant holder (or group of holders), the written consent of such disproportionately impacted holder (or group
of holders) shall also be required, and provided further that such modification, amendment or waiver applies to all of the then-outstanding
warrants.